Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ehrenstein

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|July 29, 2004
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapyMichael R Ehrenstein, Jamie G Evans, Animesh Singh, et al.
Cell Reports. Medicine|July 24, 2025
IgA2<sup>+</sup> B cells and IgA2 anti-dsDNA antibodies are selectively targeted by belimumab after rituximab therapy in systemic lupus erythematosusDaniel McCluskey, Muhammad R A Shipa, Kashfia Chowdhury, et al.
Science Translational Medicine|February 22, 2013
CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiationFabian Flores-Borja, Anneleen Bosma, Dorothy Ng, et al.
Circulation|July 22, 2009
Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient miceMyles J Lewis, Talat H Malik, Michael R Ehrenstein, et al.
Scientific Reports|March 8, 2022
A novel Streptococcus pneumoniae human challenge model demonstrates Treg lymphocyte recruitment to the infection siteGabriella Szylar, Riccardo Wysoczanski, Helina Marshall, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 2, 2014
Induced CD8+FoxP3+ Treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor α and CD86Shawn D P Ellis, Jenny L McGovern, André van Maurik, et al.
European Journal of Immunology|December 2, 2009
Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosusElizabeth C Jury, Fabian Flores-Borja, Hardeep S Kalsi, et al.
Immunity|January 19, 2010
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patientsPaul A Blair, Lina Yassin Noreña, Fabian Flores-Borja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Novel suppressive function of transitional 2 B cells in experimental arthritisJamie G Evans, Karina A Chavez-Rueda, Ayad Eddaoudi, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Elevated ferritin as a companion biomarker of myeloid-driven inflammation in RNP/Sm co-positive, treatment-resistant SLE endotypeMuhammad Ra Shipa, Claire Beesley, Daniel McClusky, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|July 29, 2004
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapyMichael R Ehrenstein, Jamie G Evans, Animesh Singh, et al.
Cell Reports. Medicine|July 24, 2025
IgA2<sup>+</sup> B cells and IgA2 anti-dsDNA antibodies are selectively targeted by belimumab after rituximab therapy in systemic lupus erythematosusDaniel McCluskey, Muhammad R A Shipa, Kashfia Chowdhury, et al.
Science Translational Medicine|February 22, 2013
CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiationFabian Flores-Borja, Anneleen Bosma, Dorothy Ng, et al.
Circulation|July 22, 2009
Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient miceMyles J Lewis, Talat H Malik, Michael R Ehrenstein, et al.
Scientific Reports|March 8, 2022
A novel Streptococcus pneumoniae human challenge model demonstrates Treg lymphocyte recruitment to the infection siteGabriella Szylar, Riccardo Wysoczanski, Helina Marshall, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 2, 2014
Induced CD8+FoxP3+ Treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor α and CD86Shawn D P Ellis, Jenny L McGovern, André van Maurik, et al.
European Journal of Immunology|December 2, 2009
Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosusElizabeth C Jury, Fabian Flores-Borja, Hardeep S Kalsi, et al.
Immunity|January 19, 2010
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patientsPaul A Blair, Lina Yassin Noreña, Fabian Flores-Borja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Novel suppressive function of transitional 2 B cells in experimental arthritisJamie G Evans, Karina A Chavez-Rueda, Ayad Eddaoudi, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Elevated ferritin as a companion biomarker of myeloid-driven inflammation in RNP/Sm co-positive, treatment-resistant SLE endotypeMuhammad Ra Shipa, Claire Beesley, Daniel McClusky, et al.
Pageof 7